 |
|
Newborn Screening for Hemoglobinopathies in ColoradoThe First 10 Years
John H. Githens, MD;
Peter A. Lane, MD;
Robert S. McCurdy, MD, MPH;
Marva L. Houston, RN;
James D. McKinna, MS;
Doris M. Cole, RN
Am J Dis Child. 1990;144(4):466-470.
Abstract
• In Colorado, newborn screening for hemoglobinopathies by cellulose acetate and citrate agar electrophoresis of dried capillary blood spots was established in 1979. We reviewed the results of screening 528 711 infants through 1988. Forty-seven infants with sickle cell diseases and 27 infants with other hemoglobin diseases were identified. The initial screening failed to detect sickle cell anemia in 4 infants, but the hemoglobinopathy in 3 of these infants was diagnosed correctly by routine retesting of those with suspected sickle cell trait. A total of 47 infants with sickle cell diseases were followed through September 1989. There was no mortality among these infants. The screening test identified 3779 infants (1:140 births) with a suspected hemoglobin trait; confirmatory retesting was obtained in 53%. The results of our experience confirm the value of newborn screening for hemoglobinopathies but suggest that a more sensitive test would improve the program.
(AJDC. 1990;144:466-470)
Author Affiliations
From the Department of Pediatrics and the Colorado Sickle Cell Treatment and Research Center, University of Colorado School of Medicine (Drs Githens and Lane and Mss Houston and Cole) and the Mountain States Newborn Screening Laboratory, Colorado Department of Health (Dr McCurdy and Mr McKinna), Denver.
Footnotes
Accepted for publication November 28, 1989.
Reprint requests to Box C-222, University of Colorado Health Sciences Center, 4200 E Ninth Ave, Denver, CO 80262 (Dr Lane).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Health Inequity in Children and Youth With Chronic Health Conditions
Berry et al.
Pediatrics 2010;126:S111-S119.
ABSTRACT
| FULL TEXT
Neonatal screening for sickle cell disease in France: evaluation of the selective process
Thuret et al.
J. Clin. Pathol. 2010;63:548-551.
ABSTRACT
| FULL TEXT
Effect of a comprehensive clinical care program on disease course in severely ill children with sickle cell anemia in a sub-Saharan African setting
Rahimy et al.
Blood 2003;102:834-838.
ABSTRACT
| FULL TEXT
Costing model for neonatal screening and diagnosis of haemoglobinopathies
Cronin et al.
Arch. Dis. Child. Fetal Neonatal Ed. 1998;79:161F-167.
ABSTRACT
| FULL TEXT
Fortnightly Review: Neonatal screening for sickle cell disorders: what about the carrier infants?
Laird et al.
BMJ 1996;313:407-411.
ABSTRACT
| FULL TEXT
|
